<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Fra samme link om at rygere i undersøgelsen havde mindre tob]]></title><description><![CDATA[<p dir="auto">And there's still more data to come. Hendershot and his team also assessed cigarette use among a subsection of participants who smoked. Though the sample size was small - just 13 of the 48 participants reported smoking cigarettes - the study found those on semaglutide tended to smoke fewer cigarettes per day, mirroring anecdotes from patients prescribed the drugs for weight loss.</p>
<p dir="auto">"Should GLP-1 receptor agonists prove efficacious for both alcohol reduction and smoking cessation," the researchers concluded, "potential health implications could be substantial."<br />
<a href="https://edition.cnn.com/2025/02/12/health/ozempic-alcohol-use-disorder-trial/index.html" rel="nofollow ugc">https://edition.cnn.com/2025/02/12/health/ozempic-alcohol-use-disorder-trial/index.html</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/447066/fra-samme-link-om-at-rygere-i-undersgelsen-havde-mindre-tob</link><generator>RSS for Node</generator><lastBuildDate>Sun, 14 Jun 2026 11:54:27 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/447066.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 13 Feb 2025 06:15:15 GMT</pubDate><ttl>60</ttl></channel></rss>